SHANG.FOS.PHARM.GR.H YC 1 (08HH) — Net Asset Momentum
SHANG.FOS.PHARM.GR.H YC 1 (08HH) recorded a net asset momentum of 3.2% as of December 2025, with net assets of €61.84 Billion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check how tangible is SHANG.FOS.PHARM.GR.H YC 1's equity to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
SHANG.FOS.PHARM.GR.H YC 1 Net Asset Momentum (2021–2025)
This chart tracks SHANG.FOS.PHARM.GR.H YC 1's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +3.2%, with net assets of €61.84 Billion EUR as of December 2025. Read 08HH total debt and obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for SHANG.FOS.PHARM.GR.H YC 1 (2021–2025)
The table below shows the complete annual net asset history for SHANG.FOS.PHARM.GR.H YC 1 from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market value of SHANG.FOS.PHARM.GR.H YC 1.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €61.84 Billion | €120.05 Billion | €58.21 Billion | ▲ +3.2% |
| 2024 | €59.93 Billion | €117.46 Billion | €57.53 Billion | ▲ +5.9% |
| 2023 | €56.62 Billion | €113.47 Billion | €56.85 Billion | ▲ +4.6% |
| 2022 | €54.11 Billion | €107.16 Billion | €53.05 Billion | ▲ +11.8% |
| 2021 | €48.38 Billion | €93.31 Billion | €44.93 Billion | — |